Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)[2] Daratumumab,
Hyaluronidase (human recombinant)		[1] D10777 [1] CD38 💬[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[1] 28
2Recombinant Human Hyaluronidase (rHuPH20)[2] Hyaluronidase,
Hyaluronidase (human recombinant)		[3] D04455 ,
D04456 ,
D06604 		--[1] 65
3Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)[2] Hyaluronidase,
Hyaluronidase (human recombinant)		[3] D04455 ,
D04456 ,
D06604 		--[1] 65